Apollo Endosurgery, Inc.
APEN dejó de cotizar en bolsa el 3 de abril de 2023.
Acerca de: Apollo Endosurgery Inc is active in the healthcare sector based in the United States. As a developer of medical devices, Apollo focuses on addressing obesity, as well as other gastrointestinal disorders. Its products are used by general surgeons, bariatric surgeons and gastroenterologists in a variety of settings to provide interventional therapy to patients who suffer from obesity. The company's products include the OverStitch Endoscopic Suturing System, X-Tack Endoscopic HeliX Tacking System, and the Orbera Intragastric Balloon System.
Empleados: 202
Noticias
No hemos recibido artículos de noticias recientes sobre APEN.